Clinical trial
Identification of Predictive Epigenetic Biomarkers of Lung Disease Severity in Cystic Fibrosis
NCT02976714 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of Predictive Epigenetic Biomarkers of Lung Disease Severity in Cystic Fibrosis
- Lead sponsor
- University Hospital, Montpellier
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 12, 2016
- Completion date
- July 13, 2021
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.